Amanda Silva Pereira

Dr. Amanda Silva Pereira

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Inês Coelho-CostaInês Coelho-Costa
Inês Coelho-Costa
Amanda Silva PereiraAmanda Silva Pereira
Amanda Silva Pereira
PMPedro Mota-Moreira
Pedro Mota-Moreira
PMPedro Marques-Couto
Pedro Marques-Couto
RTRita Teixeira-Martins
Rita Teixeira-Martins
RLRita Laiginhas
Rita Laiginhas
Background/Objectives: Diabetic retinopathy (DR) is the leading cause of preventable blindness among working-age adults. Early detection through screening programs is essential for managing the condition and preventing visual impairment. In Portugal, the national DR screening program (DR SP) targets diabetic patients, aiming to detect DR at an early stage and refer patients requiring intervention for an ophthalmology appointment. This study aims to assess the effectiveness of the Portuguese DR SP by analyzing patients referred for a hospital appointment following a positive screening result. Methods: An observational retrospective cohort study was conducted at Unidade Local de Saúde de São João (ULS-SJ), including patients referred to a DR SP hospital appointment between January 2020 and December 2023. Data were collected from hospital records upon approval by the Hospital Ethics Committee. Screening and hospital diagnoses were compared for agreement. The Chi-Square test and Cohen’s Kappa were used to assess the association between screening and hospital diagnoses. Results: A total of 1126 patients (2251 retinographies) were analyzed. The median time from screening to hospital consultation was 63 days (Interquartile Range = 39–99), though referral times varied widely within the same classifications (ranging from 8 to 354 days). The most common screening classifications were R2 (pre-proliferative DR, 47.8%) and M1 (maculopathy, 24.6%). In eyes with DR, agreement between screening and hospital diagnoses was highest for R2 (40.1%) and M1 (32.3%), while proliferative DR (R3) showed 30% agreement. The positive predictive value (PPV) of the screening program was 55.9%, with a false positive rate of 44.1%. A statistically significant association between screening and hospital diagnoses was observed (p < 0.001, Chi-Square test), though Cohen’s Kappa values (0.167 Right Eye, 0.157 Left eye) indicated only slight agreement. Conclusions: Our study found that DR SP effectively identifies patients needing ophthalmologic evaluation with moderate diagnostic agreement and a relatively high false positive rate, leading to unnecessary referrals. While this ensures that sight-threatening cases are not missed, improvements in grader training, classification protocols, and Optical Coherence Tomography (OCT) integration could improve results. Strengthening screening adherence and optimizing referral pathways would further improve the program’s impact on early DR detection and management.